S&P 500   5,018.03 (+0.14%)
DOW   37,952.09 (+0.47%)
QQQ   421.92 (-0.35%)
AAPL   165.93 (-0.66%)
MSFT   403.98 (-0.07%)
META   497.10 (-0.94%)
GOOGL   155.28 (-0.47%)
AMZN   177.49 (-0.97%)
TSLA   150.32 (+0.26%)
NVDA   841.05 (-0.67%)
AMD   150.98 (-2.64%)
NIO   3.92 (-2.00%)
BABA   68.90 (+0.03%)
T   16.36 (+0.18%)
F   12.12 (+0.50%)
MU   110.35 (-1.41%)
GE   153.02 (+0.05%)
CGC   8.11 (+3.58%)
DIS   112.06 (-0.33%)
AMC   2.89 (-1.03%)
PFE   25.41 (+0.08%)
PYPL   62.35 (+0.40%)
XOM   119.54 (+0.86%)
S&P 500   5,018.03 (+0.14%)
DOW   37,952.09 (+0.47%)
QQQ   421.92 (-0.35%)
AAPL   165.93 (-0.66%)
MSFT   403.98 (-0.07%)
META   497.10 (-0.94%)
GOOGL   155.28 (-0.47%)
AMZN   177.49 (-0.97%)
TSLA   150.32 (+0.26%)
NVDA   841.05 (-0.67%)
AMD   150.98 (-2.64%)
NIO   3.92 (-2.00%)
BABA   68.90 (+0.03%)
T   16.36 (+0.18%)
F   12.12 (+0.50%)
MU   110.35 (-1.41%)
GE   153.02 (+0.05%)
CGC   8.11 (+3.58%)
DIS   112.06 (-0.33%)
AMC   2.89 (-1.03%)
PFE   25.41 (+0.08%)
PYPL   62.35 (+0.40%)
XOM   119.54 (+0.86%)
S&P 500   5,018.03 (+0.14%)
DOW   37,952.09 (+0.47%)
QQQ   421.92 (-0.35%)
AAPL   165.93 (-0.66%)
MSFT   403.98 (-0.07%)
META   497.10 (-0.94%)
GOOGL   155.28 (-0.47%)
AMZN   177.49 (-0.97%)
TSLA   150.32 (+0.26%)
NVDA   841.05 (-0.67%)
AMD   150.98 (-2.64%)
NIO   3.92 (-2.00%)
BABA   68.90 (+0.03%)
T   16.36 (+0.18%)
F   12.12 (+0.50%)
MU   110.35 (-1.41%)
GE   153.02 (+0.05%)
CGC   8.11 (+3.58%)
DIS   112.06 (-0.33%)
AMC   2.89 (-1.03%)
PFE   25.41 (+0.08%)
PYPL   62.35 (+0.40%)
XOM   119.54 (+0.86%)
S&P 500   5,018.03 (+0.14%)
DOW   37,952.09 (+0.47%)
QQQ   421.92 (-0.35%)
AAPL   165.93 (-0.66%)
MSFT   403.98 (-0.07%)
META   497.10 (-0.94%)
GOOGL   155.28 (-0.47%)
AMZN   177.49 (-0.97%)
TSLA   150.32 (+0.26%)
NVDA   841.05 (-0.67%)
AMD   150.98 (-2.64%)
NIO   3.92 (-2.00%)
BABA   68.90 (+0.03%)
T   16.36 (+0.18%)
F   12.12 (+0.50%)
MU   110.35 (-1.41%)
GE   153.02 (+0.05%)
CGC   8.11 (+3.58%)
DIS   112.06 (-0.33%)
AMC   2.89 (-1.03%)
PFE   25.41 (+0.08%)
PYPL   62.35 (+0.40%)
XOM   119.54 (+0.86%)
NASDAQ:BSGM

BioSig Technologies (BSGM) Stock Price, News & Analysis

$1.50
-0.04 (-2.60%)
(As of 09:36 AM ET)
Today's Range
$1.46
$1.56
50-Day Range
$0.32
$2.01
52-Week Range
$0.26
$16.50
Volume
15,976 shs
Average Volume
981,193 shs
Market Capitalization
$16.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
BSGM stock logo

About BioSig Technologies Stock (NASDAQ:BSGM)

BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias. The company offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for catheter ablation procedures for arrhythmias. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

BSGM Stock Price History

BSGM Stock News Headlines

BioSig Technologies Inc.
I’m officially sounding the alarm.
AI has been the hottest financial story of 2023. And rightly so – AI stocks have beat the broader market by over 62%. But right now, my system is warning me that many AI stocks are riding higher on hype alone.
Biosig Technologies Inc (BSGM)
I’m officially sounding the alarm.
AI has been the hottest financial story of 2023. And rightly so – AI stocks have beat the broader market by over 62%. But right now, my system is warning me that many AI stocks are riding higher on hype alone.
BioSig Announces Reduction of its Workforce
BioSig Announces Reduction of its Workforce
BioSig Technologies Inc BSGM
See More Headlines
Receive BSGM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioSig Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/31/2022
Today
4/18/2024
Next Earnings (Estimated)
5/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:BSGM
Fax
N/A
Employees
47
Year Founded
N/A

Profitability

Net Income
$-27,050,000.00
Pretax Margin
-20,963.12%

Debt

Sales & Book Value

Annual Sales
$20,000.00
Book Value
$0.05 per share

Miscellaneous

Free Float
8,147,000
Market Cap
$13.83 million
Optionable
Optionable
Beta
1.21
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

BSGM Stock Analysis - Frequently Asked Questions

How have BSGM shares performed in 2024?

BioSig Technologies' stock was trading at $4.75 at the beginning of the year. Since then, BSGM stock has decreased by 67.6% and is now trading at $1.54.
View the best growth stocks for 2024 here
.

When is BioSig Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our BSGM earnings forecast
.

How were BioSig Technologies' earnings last quarter?

BioSig Technologies, Inc. (NASDAQ:BSGM) released its earnings results on Thursday, March, 31st. The company reported ($2.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($2.20) by $0.20.

When did BioSig Technologies' stock split?

BioSig Technologies's stock reverse split before market open on Friday, February 2nd 2024. The 1-10 reverse split was announced on Friday, February 2nd 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, February 2nd 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of BioSig Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BioSig Technologies investors own include Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pfizer (PFE), Roku (ROKU), Advanced Micro Devices (AMD), Amarin (AMRN), Dynavax Technologies (DVAX), Vaxart (VXRT), Telefonaktiebolaget LM Ericsson (publ) (ERIC) and Micron Technology (MU).

How do I buy shares of BioSig Technologies?

Shares of BSGM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BSGM) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners